Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

CRH (CRH.L)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (p) Price Target (p) Rating
2021-01-2631313600Buy
2021-04-3034273775Buy
2021-08-2738874275Buy
2021-11-2438314450Buy
2022-03-0729894330Buy
2022-04-2731694425Buy
2022-08-2632164200Buy
2023-03-0342564850Buy
2023-08-2545085060Buy
2023-11-2249165560Buy
2024-01-2353826350Buy
2024-03-0466347525Buy

Disclosures

  • UBS Securities Australia Limited is acting as advisor to CRH plc (CRH.L) on their acquisition of Adbri Ltd (ABC.AX) and will receive a fee for these services
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS AG London Branch acts as broker to this company.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.